カテゴリー： 未分類

医療用亜酸化窒素のグローバル市場予測（～2029）：気体、液体

【英語タイトル】Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anaesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria - Global Forecast to 2029

MarketsandMarketsが出版した調査資料（MD8935-24）・商品コード：MD8935-24
・発行会社（調査会社）：MarketsandMarkets
・発行日：2024年2月
・ページ数：202
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：化学
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

“医療用亜酸化窒素の世界市場規模は、2023年の18億米ドルから2029年には28億米ドルになると推定され、年平均成長率は6.6%となる見込み”
医療用亜酸化窒素市場の拡大は、主に高齢者人口の増加、医療インフラの進歩、非侵襲的な苦痛緩和方法への要望、医療用ガスの使用を管理する支持的な規制の存在など、様々な要因によって促進されています。さらに、先進国および発展途上国の両方で顕著な外科手術の急増は、麻酔および鎮痛における医療用亜酸化窒素の利用を高める好機を生み出し、産業のさらなる成長展望への道を開きます。

“気体セグメントが2023年に最大の市場シェアを占める見込み”
医療用亜酸化窒素市場は、製品に基づいて気体状態と液体状態に区分されます。2023年現在、気体セグメントが市場を支配しています。医療用亜酸化窒素市場における気体状態の普及は、特に外科手術中の麻酔や鎮痛など、その用途の多様性に起因しています。医療環境において気体形態が好まれるのは、投与が容易で、投与量を正確に制御でき、作用の発現が速いためです。

“予測期間中、麻酔と鎮痛の分野が最も高い成長率を記録”
医療用亜酸化窒素市場は、用途別に麻酔と鎮痛、凍結手術、外科用気腹に区分されます。2023年現在、予測期間中に最も高い成長を記録すると予想されるのは麻酔と鎮痛セグメントです。医療用亜酸化窒素市場における麻酔と鎮痛用途の優位性は、外科手術と医療処置の両方における極めて重要な役割によるものです。亜酸化窒素は、その麻酔および鎮痛特性で有名であり、様々な医療介入中に意識的鎮静を誘導し、痛みを和らげる効果があるため、医療現場で広く受け入れられています。この優位性は、医療専門家による亜酸化窒素の広範な使用によって強調されています。亜酸化窒素は、迅速かつ制御可能な鎮静を提供し、患者の快適さと手順の成功を大幅に向上させるからです。

“2023年、病院セグメントが脳モニタリング市場で最大のシェアを占める見込み”
医療用亜酸化窒素市場は、エンドユーザー別に病院、在宅医療、学術・研究機関に分類されます。2023年現在、病院セグメントが市場を支配しています。これは主に、特に外科手術や医療処置において、病院内での亜酸化窒素の重要な役割によるものです。総合的なヘルスケアサービスの中心的なハブとして機能している病院は、麻酔と鎮痛のために亜酸化窒素を広範囲に使用しており、外科的介入中の患者の鎮静のために制御された効果的な方法を提供しています。

“予測期間中、医療用亜酸化窒素市場において北米が最大の地域セグメントに”
地域に基づき、世界の医療用亜酸化窒素市場は、北米、ヨーロッパ、アジア太平洋地域、ラテンアメリカ、中東・アフリカに分けられます。北米は2023年に市場で最大のシェアを占めると予想されています。アジア太平洋地域は、予測期間中に最も急速な成長を遂げると予測されています。アジア太平洋地域における市場の大幅な拡大は、医療インフラのダイナミックな成長、外科手術の増加、亜酸化窒素の利点に対する意識の高まりに起因しています。これらの要因がAPAC地域における医療用亜酸化窒素の需要増加の要因となっています。

主な参加者の内訳
主な参加者の内訳は以下の通りです：
- 企業タイプ別 - Tier 1-35%、Tier 2-45%、Tier 3-20%
- 役職別 - Cレベル-35%、ディレクターレベル-25%、その他-40%
- 地域別 - 北米-45%、ヨーロッパ-30%、アジア太平洋地域-20%、ラテンアメリカ-3%、中東・アフリカ-2%

医療用亜酸化窒素市場の主な企業は、Carbide and Chemicals（インド）、nexAir（米国）、Air Liquide（パリ）、Linde plc（アイルランド）、Southern Gas Limited（インド）、Jiangsu Huazhong Gas Co. （中国）、American Welding & Gas（米国）、Oxygen & Argon Works Ltd（イスラエル）、Matheson Tri-Gas Inc.（米国）、CalOx（米国）、Steelman Gases Pvt. Ltd.（インド）、Earlbeck Gases & Technology（米国）、Chengdu Taiyu Industrial Gases Co., Ltd.（中国）、Messer SE & CO. KGAA（ドイツ）、SOL SpA（イタリア）、Ellenbarrie Industrial Gases（インド）、Norco Inc.（米国）、Gulf Cryo（アラブ首長国連邦）などです。

調査範囲
本レポートでは、医療用亜酸化窒素市場を地域 （アジア太平洋、ヨーロッパ、北米、中南米、中東・アフリカ）、製品 （ガス状、液体）、用途 （麻酔・疼痛緩和、凍結手術、手術用インフレーション）、エンドユーザー （病院、在宅医療、学術・研究機関） に基づいて分類しています。
また、医療用亜酸化窒素市場における市場促進要因、阻害要因、機会についても包括的にレビューしています。

レポート購入の主な利点
本レポートは、市場全体およびサブセグメントの収益数値に最も近い近似値に関する情報を提供し、この市場のリーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは医療用亜酸化窒素市場の鼓動を理解し、主要な市場促進要因、阻害要因、課題、機会に関する情報を関係者に提供します。

レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握するのに役立ちます。本レポートを購入された企業は、以下の戦略のいずれか、または任意の組み合わせを使用して、市場での地位を強化することができます。

本レポートでは、以下のポイントに関する洞察を提供しています：
o 主な促進要因（高齢者人口の増加、医療インフラの進歩、痛みを和らげるための非侵襲的な方法に対する需要、医療ガスの使用に関する支持的な規制や基準）、阻害要因（安全性への懸念、代替品の入手可能性、環境への懸念）、機会（新興市場、小児用）、課題（限られた認知度、経済的要因）の分析。
o 市場浸透： 世界の医療用亜酸化窒素市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報。本レポートでは、この市場を製品、用途、エンドユーザー別に分析しています。
o 製品の強化/革新： 医療用亜酸化窒素の世界市場における今後の動向と製品発売に関する詳細な洞察
o 市場開発： 製品、用途、エンドユーザー別の有利な新興市場に関する包括的な情報。
o 市場の多様化： 医療用亜酸化窒素の世界市場における新製品や製品の強化、成長地域、最近の開発、投資に関する詳細情報
o 競合評価： 世界の医療用亜酸化窒素市場における主要企業の市場占有率、成長戦略、製品提供、競争上のリーダーシップマッピング、および能力に関する詳細な評価。

1 はじめに
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 医療用亜酸化窒素市場：種類別
7 医療用亜酸化窒素市場：用途別
8 医療用亜酸化窒素市場：エンドユーザー別
9 医療用亜酸化窒素市場：地域別
10 競争状況
11 企業プロファイル
12 付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 MARKETS COVERED 30
FIGURE 1 MEDICAL NITROUS OXIDE MARKET SEGMENTATION 30
1.3.1 REGIONAL SEGMENTATION 30
1.3.2 YEARS CONSIDERED 31
1.3.3 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 31
1.5 RECESSION IMPACT 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 2 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY RESEARCH 35
2.1.2.1 Primary sources 36
2.1.2.2 Key data from primary sources 37
2.1.2.3 Key industry insights 37
2.1.2.4 Breakdown of primary interviews: by company type, designation, and region 38
2.2 MARKET SIZE ESTIMATION METHODOLOGY 38
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 39
2.3 MARKET ESTIMATION 39
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 40
FIGURE 5 MEDICAL NITROUS OXIDE MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR AIR LIQUIDE S.A. 40
FIGURE 6 MEDICAL NITROUS OXIDE MARKET: DEMAND-SIDE MODELING 41
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL NITROUS OXIDE MARKET (2023–2029) 42
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
2.4 MARKET DATA ESTIMATION AND TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.5 STUDY ASSUMPTIONS 45
2.6 LIMITATIONS 45
2.6.1 SCOPE-RELATED LIMITATIONS 45
2.6.2 METHODOLOGY-RELATED LIMITATIONS 45
2.7 RISK ASSESSMENT 46
TABLE 1 RISK ASSESSMENT: MEDICAL NITROUS OXIDE MARKET 46
2.8 MEDICAL NITROUS OXIDE MARKET: RECESSION IMPACT 46
3 EXECUTIVE SUMMARY 47
FIGURE 10 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2023 VS. 2029 (USD MILLION) 47
FIGURE 11 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION) 48
FIGURE 12 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) 48
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF MEDICAL NITROUS OXIDE MARKET 49
4 PREMIUM INSIGHTS 50
4.1 MEDICAL NITROUS OXIDE MARKET OVERVIEW 50
FIGURE 14 INCREASING NUMBER OF SURGERIES AND DENTAL PROCEDURES TO DRIVE MARKET GROWTH 50
4.2 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE AND COUNTRY (2022) 51
FIGURE 15 LIQUID NITROUS OXIDE SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022 51
4.3 MEDICAL NITROUS OXIDE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 51
FIGURE 16 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 51
4.4 MEDICAL NITROUS OXIDE MARKET: REGIONAL MIX 52
FIGURE 17 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 52
4.5 MEDICAL NITROUS OXIDE MARKET: DEVELOPED VS. EMERGING ECONOMIES 52
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 19 MEDICAL NITROUS OXIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS 54
5.2.1 DRIVERS 54
5.2.1.1 Increasing number of surgeries and dental procedures 54
5.2.1.2 Growing adoption of nitrous oxide across various medical specialties 55
5.2.1.3 Rising geriatric population and subsequent increase in prevalence of chronic diseases 55
FIGURE 20 GLOBAL GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION) 55
5.2.1.4 Growing demand for home healthcare 56
5.2.2 RESTRAINTS 56
5.2.2.1 Potential risks associated with nitrous oxide misuse 56
5.2.2.2 Availability of alternatives 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 Rising demand for pain management 57
FIGURE 21 PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021 57
5.2.3.2 Technological advancements 58
5.2.4 CHALLENGES 58
5.2.4.1 Changes in calibration standards 58
5.2.4.2 Lack of awareness 58
5.3 INDUSTRY TRENDS 59
5.3.1 ADVANCEMENTS IN NITROUS OXIDE DELIVERY SYSTEMS 59
5.3.2 GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 59
5.4 TECHNOLOGY ANALYSIS 60
5.4.1 KEY TECHNOLOGIES 60
5.4.1.1 Nitrous oxide delivery systems 60
5.4.1.2 Monitoring and control systems 60
5.4.1.3 Technological integration in anesthesia machines 60
5.4.2 COMPLEMENTARY TECHNOLOGIES 60
5.4.2.1 Patient monitoring devices 60
5.4.2.2 Smart devices and connectivity 60
5.4.3 ADJACENT TECHNOLOGIES 61
5.4.3.1 Advanced anesthetic agents 61
5.4.3.2 Surgical robotics 61
5.5 PRICING ANALYSIS 61
5.5.1 AVERAGE SELLING PRICE TREND OF MEDICAL NITROUS OXIDE, BY PRODUCT 61
TABLE 3 AVERAGE SELLING PRICE OF MEDICAL NITROUS OXIDE, BY PRODUCT TYPE (USD) 61
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 61
5.6 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 4 PORTER’S FIVE FORCES ANALYSIS 62
5.6.1 INTENSITY OF COMPETITIVE RIVALRY 62
5.6.2 BARGAINING POWER OF SUPPLIERS 62
5.6.3 BARGAINING POWER OF BUYERS 62
5.6.4 THREAT OF SUBSTITUTES 62
5.6.5 THREAT OF NEW ENTRANTS 63
5.7 TARIFF & REGULATORY ANALYSIS 63
5.7.1 TARIFF FOR MEDICAL NITROUS OXIDE 63
5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
5.7.3 NORTH AMERICA 63
5.7.3.1 US 63
TABLE 5 US: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 64
5.7.3.2 Canada 64
TABLE 6 CANADA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
5.7.4 EUROPE 65
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS 66
5.7.5 ASIA PACIFIC 67
5.7.5.1 Japan 67
TABLE 8 JAPAN: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.7.5.2 China 67
TABLE 9 CHINA: STANDARDS FOR MEDICAL GAS EQUIPMENT 68
TABLE 10 CHINA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
5.7.5.3 India 69
TABLE 11 INDIA: STANDARDS FOR MEDICAL GAS EQUIPMENT 69
TABLE 12 INDIA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
5.7.6 LATIN AMERICA AND MIDDLE EAST & AFRICA 70
TABLE 13 LATIN AMERICA AND MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
5.8 VALUE CHAIN ANALYSIS 71
FIGURE 22 VALUE CHAIN ANALYSIS 71
5.9 ECOSYSTEM ANALYSIS 72
TABLE 14 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM MAPPING 72
FIGURE 23 MEDICAL NITROUS OXIDE MARKET: ECOSYSTEM 73
5.10 CASE STUDY ANALYSIS 73
5.10.1 CASE STUDY: EAST LANCASHIRE TEACHING HOSPITAL NHS FOUNDATION TRUST (ELHT) 73
5.11 PATENT ANALYSIS 74
5.11.1 PATENT PUBLICATION TRENDS 74
FIGURE 24 PATENT PUBLICATION TRENDS, 2014–2024 74
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024) 75
TABLE 15 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MEDICAL NITROUS OXIDE PATENTS 75
5.11.3 MEDICAL NITROUS OXIDE MARKET: TOP APPLICANTS 75
FIGURE 25 TOP APPLICANTS FOR MEDICAL NITROUS OXIDE PATENTS (2014–2024) 75
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 76
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE PRODUCTS 76
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 77
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL NITROUS OXIDE END USERS 77
5.12.2 BUYING CRITERIA 77
FIGURE 27 KEY BUYING CRITERIA FOR END USERS IN MEDICAL NITROUS OXIDE MARKET 77
TABLE 18 KEY BUYING CRITERIA FOR MEDICAL NITROUS OXIDE MARKET 78
5.13 KEY CONFERENCES & EVENTS IN 2024 78
TABLE 19 MEDICAL NITROUS OXIDE MARKET: DETAILED LIST OF CONFERENCES & EVENTS 78
5.14 TRADE ANALYSIS 79
5.14.1 TRADE ANALYSIS FOR MEDICAL NITROUS OXIDE 79
FIGURE 28 PRODUCT IMPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND) 79
FIGURE 29 PRODUCT EXPORTS UNDER HSN CODE 281129, BY COUNTRY, 2022 (USD THOUSAND) 80
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80
FIGURE 30 REVENUE SHIFT IN MEDICAL NITROUS OXIDE MARKET 80
5.16 UNMET NEEDS ANALYSIS 81
TABLE 20 UNMET NEEDS IN MEDICAL NITROUS OXIDE MARKET 81
5.16.1 END-USER EXPECTATIONS 82
TABLE 21 END-USER EXPECTATIONS IN MEDICAL NITROUS OXIDE MARKET 82
6 MEDICAL NITROUS OXIDE MARKET, BY TYPE 83
6.1 INTRODUCTION 84
TABLE 22 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 84
TABLE 23 MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 84
6.2 LIQUID NITROUS OXIDE 84
6.2.1 RISING CRYOTHERAPY APPLICATIONS TO DRIVE MARKET 84
TABLE 24 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 85
TABLE 25 LIQUID MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 86
6.3 GASEOUS NITROUS OXIDE 86
6.3.1 PRECISE DOSAGE CONTROL AND PORTABILITY TO DRIVE MARKET GROWTH 86
TABLE 26 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 87
TABLE 27 GASEOUS MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 88
7 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION 89
7.1 INTRODUCTION 90
TABLE 28 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 90
TABLE 29 MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 90
7.2 ANESTHESIA & PAIN RELIEF 90
7.2.1 WIDE USAGE AS CARRIER FOR OTHER ANESTHETIC GASES TO DRIVE MARKET 90
TABLE 30 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2018–2021 (USD MILLION) 91
TABLE 31 MEDICAL NITROUS OXIDE MARKET FOR ANESTHESIA & PAIN RELIEF, BY COUNTRY, 2022–2029 (USD MILLION) 92
7.3 CRYOSURGERY 92
7.3.1 PAINLESSNESS OF CRYOSURGICAL PROCEDURES TO SUPPORT ADOPTION 92
TABLE 32 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2018–2021 (USD MILLION) 93
TABLE 33 MEDICAL NITROUS OXIDE MARKET FOR CRYOSURGERY, BY COUNTRY, 2022–2029 (USD MILLION) 94
7.4 SURGICAL INSUFFLATION 94
7.4.1 USE OF NITROUS OXIDE AS INSUFFLATION GAS IN LAPAROSCOPIC AND ENDOSCOPIC SURGERIES TO DRIVE MARKET 94
TABLE 34 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2018–2021 (USD MILLION) 95
TABLE 35 MEDICAL NITROUS OXIDE MARKET FOR SURGICAL INSUFFLATION, BY COUNTRY, 2022–2029 (USD MILLION) 96
8 MEDICAL NITROUS OXIDE MARKET, BY END USER 97
8.1 INTRODUCTION 98
TABLE 36 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 98
TABLE 37 MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 98
8.2 HOSPITALS 98
8.2.1 EXTENSIVE USAGE OF MEDICAL NITROUS OXIDE TO DRIVE MARKET 98
TABLE 38 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2018–2021 (USD MILLION) 99
TABLE 39 MEDICAL NITROUS OXIDE MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION) 100
8.3 HOME CARE SETTINGS 100
8.3.1 HOME CARE SETTINGS TO WITNESS HIGHEST GROWTH DUE TO RISING PREVALENCE OF CHRONIC DISEASES 100
TABLE 40 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION) 101
TABLE 41 MEDICAL NITROUS OXIDE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION) 102
8.4 ACADEMIC & RESEARCH INSTITUTES 102
8.4.1 COLLABORATION WITH INDUSTRY PARTNERS FOR TECHNOLOGICAL ADVANCES TO SUPPORT GROWTH 102
TABLE 42 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2021 (USD MILLION) 103
TABLE 43 MEDICAL NITROUS OXIDE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 104
9 MEDICAL NITROUS OXIDE MARKET, BY REGION 105
9.1 INTRODUCTION 106
TABLE 44 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2018–2021 (USD MILLION) 106
TABLE 45 MEDICAL NITROUS OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION) 106
9.2 NORTH AMERICA 107
9.2.1 NORTH AMERICA: RECESSION IMPACT 107
FIGURE 31 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET SNAPSHOT 108
TABLE 46 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 109
TABLE 47 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109
TABLE 48 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 109
TABLE 49 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 110
TABLE 50 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 110
TABLE 51 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 110
TABLE 52 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 111
TABLE 53 NORTH AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 111
9.2.2 US 111
9.2.2.1 US to dominate North American medical nitrous oxide market 111
TABLE 54 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 112
TABLE 55 US: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 112
TABLE 56 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 112
TABLE 57 US: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 113
TABLE 58 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 113
TABLE 59 US: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 113
9.2.3 CANADA 114
9.2.3.1 Stringent regulatory compliance to support market growth in Canada 114
TABLE 60 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 114
TABLE 61 CANADA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 114
TABLE 62 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 115
TABLE 63 CANADA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 115
TABLE 64 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 115
TABLE 65 CANADA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 116
9.3 EUROPE 116
9.3.1 EUROPE: RECESSION IMPACT 116
TABLE 66 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 117
TABLE 67 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 68 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 117
TABLE 69 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 118
TABLE 70 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 118
TABLE 71 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 118
TABLE 72 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 119
TABLE 73 EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 119
9.3.2 GERMANY 119
9.3.2.1 Increasing healthcare spending to drive market 119
TABLE 74 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 120
TABLE 75 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 120
TABLE 76 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 120
TABLE 77 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 121
TABLE 78 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 121
TABLE 79 GERMANY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 121
9.3.3 UK 122
9.3.3.1 Increasing surgeries & dental procedures to drive market 122
TABLE 80 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 122
TABLE 81 UK: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 82 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 123
TABLE 83 UK: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 123
TABLE 84 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 123
TABLE 85 UK: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 124
9.3.4 FRANCE 124
9.3.4.1 Well-established healthcare system to drive market 124
TABLE 86 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 124
TABLE 87 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 125
TABLE 88 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 125
TABLE 89 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 125
TABLE 90 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 126
TABLE 91 FRANCE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 126
9.3.5 ITALY 126
9.3.5.1 Rapid growth in geriatric population and rising life expectancy to favor market growth 126
TABLE 92 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 127
TABLE 93 ITALY: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 127
TABLE 94 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 127
TABLE 95 ITALY: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 128
TABLE 96 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 128
TABLE 97 ITALY: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 128
9.3.6 SPAIN 129
9.3.6.1 Increasing prevalence of cancer to support market growth 129
TABLE 98 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 129
TABLE 99 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
TABLE 100 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 129
TABLE 101 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 130
TABLE 102 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 130
TABLE 103 SPAIN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 130
9.3.7 REST OF EUROPE 131
TABLE 104 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 131
TABLE 105 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 131
TABLE 106 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 132
TABLE 107 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 132
TABLE 108 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 132
TABLE 109 REST OF EUROPE: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 133
9.4 ASIA PACIFIC 133
9.4.1 ASIA PACIFIC: RECESSION IMPACT 133
FIGURE 32 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET SNAPSHOT 134
TABLE 110 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2018–2021 (USD MILLION) 135
TABLE 111 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 112 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 135
TABLE 113 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 136
TABLE 114 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 136
TABLE 115 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 136
TABLE 116 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 137
TABLE 117 ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 137
9.4.2 JAPAN 137
9.4.2.1 Japan to hold largest share of APAC market 137
TABLE 118 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 138
TABLE 119 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 138
TABLE 120 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 138
TABLE 121 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 139
TABLE 122 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 139
TABLE 123 JAPAN: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 139
9.4.3 CHINA 140
9.4.3.1 Strong investments in infrastructural development to offer opportunities for market growth 140
TABLE 124 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 140
TABLE 125 CHINA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 140
TABLE 126 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 141
TABLE 127 CHINA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 141
TABLE 128 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 141
TABLE 129 CHINA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 142
9.4.4 INDIA 142
9.4.4.1 Rising procedural volume to ensure sustained demand for medical gases 142
TABLE 130 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 142
TABLE 131 INDIA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 132 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 143
TABLE 133 INDIA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 143
TABLE 134 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 144
TABLE 135 INDIA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 144
9.4.5 REST OF ASIA PACIFIC 144
TABLE 136 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 144
TABLE 137 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 145
TABLE 138 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 145
TABLE 139 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 145
TABLE 140 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 146
TABLE 141 REST OF ASIA PACIFIC: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 146
9.5 LATIN AMERICA 146
9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTHCARE DEVELOPMENT TO PROMOTE ADOPTION OF MEDICAL NITROUS OXIDE 146
9.5.2 LATIN AMERICA: RECESSION IMPACT 147
TABLE 142 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 147
TABLE 143 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 147
TABLE 144 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 147
TABLE 145 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 148
TABLE 146 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 148
TABLE 147 LATIN AMERICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 148
9.6 MIDDLE EAST & AFRICA 149
9.6.1 GOVERNMENT INITIATIVES FOR INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET GROWTH 149
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 149
TABLE 148 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2018–2021 (USD MILLION) 149
TABLE 149 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY TYPE, 2022–2029 (USD MILLION) 150
TABLE 150 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2018–2021 (USD MILLION) 150
TABLE 151 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 150
TABLE 152 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2018–2021 (USD MILLION) 151
TABLE 153 MIDDLE EAST & AFRICA: MEDICAL NITROUS OXIDE MARKET, BY END USER, 2022–2029 (USD MILLION) 151
10 COMPETITIVE LANDSCAPE 152
10.1 OVERVIEW 152
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 152
TABLE 154 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL NITROUS OXIDE MARKET 153
10.3 REVENUE ANALYSIS 154
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL NITROUS OXIDE MARKET, 2018–2022 (USD MILLION) 154
10.4 MARKET SHARE ANALYSIS 154
FIGURE 34 MEDICAL NITROUS OXIDE MARKET SHARE ANALYSIS (2022) 155
TABLE 155 MEDICAL NITROUS OXIDE MARKET: DEGREE OF COMPETITION 155
10.5 MARKET RANKING ANALYSIS 156
FIGURE 35 MEDICAL NITROUS OXIDE MARKET RANKING, BY KEY PLAYER, 2022 156
10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS 157
10.6.1 STARS 157
10.6.2 EMERGING LEADERS 157
10.6.3 PERVASIVE PLAYERS 158
10.6.4 PARTICIPANTS 158
FIGURE 36 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 158
10.6.5 COMPANY FOOTPRINT 159
FIGURE 37 MEDICAL NITROUS OXIDE MARKET: COMPANY FOOTPRINT 159
TABLE 156 MEDICAL NITROUS OXIDE MARKET: TYPE FOOTPRINT 160
TABLE 157 MEDICAL NITROUS OXIDE MARKET: APPLICATION FOOTPRINT 161
TABLE 158 MEDICAL NITROUS OXIDE MARKET: END-USER FOOTPRINT 162
TABLE 159 MEDICAL NITROUS OXIDE MARKET: REGIONAL FOOTPRINT 163
10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES 164
10.7.1 PROGRESSIVE COMPANIES 164
10.7.2 RESPONSIVE COMPANIES 164
10.7.3 DYNAMIC COMPANIES 164
10.7.4 STARTING BLOCKS 164
FIGURE 38 MEDICAL NITROUS OXIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 165
10.7.5 COMPETITIVE BENCHMARKING 166
10.7.5.1 Detailed list of key startups/SMEs 166
TABLE 160 MEDICAL NITROUS OXIDE: DETAILED LIST OF KEY STARTUPS/SMES 166
10.7.5.2 Competitive benchmarking of key startups/SMEs 167
TABLE 161 MEDICAL NITROUS OXIDE: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 167
10.8 BRAND/PRODUCT COMPARISON 168
10.9 COMPANY EVALUATION AND FINANCIAL METRICS 169
FIGURE 39 EV/EBITDA OF KEY VENDORS 169
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MEDICAL NITROUS OXIDE VENDORS 169
10.10 COMPETITIVE SCENARIO 170
10.10.1 DEALS 170
TABLE 162 MEDICAL NITROUS OXIDE MARKET: DEALS, JANUARY 2020– JANUARY 2024 170
10.10.2 EXPANSIONS 171
TABLE 163 MEDICAL NITROUS OXIDE MARKET: EXPANSIONS, JANUARY 2020–JANUARY 2024 171
11 COMPANY PROFILES 172
11.1 KEY PLAYERS 172
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 AIR LIQUIDE 172
TABLE 164 AIR LIQUIDE: COMPANY OVERVIEW 172
FIGURE 41 AIR LIQUIDE: COMPANY SNAPSHOT (2022) 173
11.1.2 LINDE PLC 175
TABLE 165 LINDE PLC: COMPANY OVERVIEW 175
FIGURE 42 LINDE PLC: COMPANY SNAPSHOT (2022) 176
11.1.3 SOL SPA 178
TABLE 166 SOL SPA: COMPANY OVERVIEW 178
FIGURE 43 SOL SPA: COMPANY SNAPSHOT (2022) 179
11.1.4 TAIYO NIPPON SANSO CORPORATION 181
TABLE 167 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW 181
FIGURE 44 TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2023) 182
11.1.5 NORCO INC. 184
TABLE 168 NORCO INC.: COMPANY OVERVIEW 184
11.1.6 SOUTHERN GAS LIMITED 186
TABLE 169 SOUTHERN GAS LIMITED: COMPANY OVERVIEW 186
FIGURE 45 SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2022) 186
11.1.7 ELLENBARRIE INDUSTRIAL GASES 187
TABLE 170 ELLENBARRIE INDUSTRIAL GASES: COMPANY OVERVIEW 187
FIGURE 46 ELLENBARRIE INDUSTRIAL GASES: COMPANY SNAPSHOT (2020) 187
11.1.8 CALOX INC. 188
TABLE 171 CALOX INC.: COMPANY OVERVIEW 188
11.1.9 STEELMAN GASES PVT. LTD. 189
TABLE 172 STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW 189
11.1.10 NEXAIR 190
TABLE 173 NEXAIR: COMPANY OVERVIEW 190
11.1.11 OXYGEN & ARGON WORKS LTD. 192
TABLE 174 OXYGEN & ARGON WORKS LTD.: COMPANY OVERVIEW 192
11.1.12 GULFCRYO 193
TABLE 175 GULFCRYO: COMPANY OVERVIEW 193
11.1.13 CHENGDU TAIYO INDUSTRIAL GASES CO., LTD. 194
TABLE 176 CHENGDU TAIYO INDUSTRIAL GASES CO. LTD.: COMPANY OVERVIEW 194
11.1.14 JIANGSU HUAZHONG GAS CO., LTD. 195
TABLE 177 JIANGSU HAUZHONG GAS CO., LTD.: COMPANY OVERVIEW 195
11.1.15 CARBIDE AND CHEMICALS 196
TABLE 178 CARBIDE AND CHEMICALS: COMPANY OVERVIEW 196
11.1.16 AMERICAN WELDING & GAS 197
TABLE 179 AMERICAN WELDING & GAS: COMPANY OVERVIEW 197
11.1.17 ASIA INDUSTRIAL GASES PTE. LTD. 198
TABLE 180 ASIA INDUSTRIAL GASES PTE. LTD.: COMPANY OVERVIEW 198
11.1.18 MIDDLESEX GASES & TECHNOLOGY INC. 199
TABLE 181 MIDDLESEX GASES & TECHNOLOGIES INC.: COMPANY OVERVIEW 199
11.1.19 AMERITANX CYLINDERS 200
TABLE 182 AMERITANX CYLINDERS: COMPANY OVERVIEW 200
11.1.20 CRYOCARB 201
TABLE 183 CRYOCARB: COMPANY OVERVIEW 201
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 202
11.2.1 HOLSTON GASES 202
11.2.2 AOPL 202
11.2.3 BUTLER GAS PRODUCTS COMPANY 203
11.2.4 GRUPPO SIAD 203
11.2.5 ANDY OXY CO., INC. 203
12 APPENDIX 204
12.1 DISCUSSION GUIDE 204
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 206
12.3 CUSTOMIZATION OPTIONS 208
12.4 RELATED REPORTS 208
12.5 AUTHOR DETAILS 209



❖ 世界の医療用亜酸化窒素市場に関するよくある質問(FAQ) ❖

・医療用亜酸化窒素の世界市場規模は？
→MarketsandMarkets社は2023年の医療用亜酸化窒素の世界市場規模を18億米ドルと推定しています。

・医療用亜酸化窒素の世界市場予測は？
→MarketsandMarkets社は2029年の医療用亜酸化窒素の世界市場規模を28億米ドルと予測しています。

・医療用亜酸化窒素市場の成長率は？
→MarketsandMarkets社は医療用亜酸化窒素の世界市場が2023年～2029年に年平均6.6%成長すると予測しています。

・世界の医療用亜酸化窒素市場における主要企業は？
→MarketsandMarkets社は「Carbide and Chemicals（インド）、nexAir（米国）、Air Liquide（パリ）、Linde plc（アイルランド）、Southern Gas Limited（インド）、Jiangsu Huazhong Gas Co. （中国）、American Welding & Gas（米国）、Oxygen & Argon Works Ltd（イスラエル）、Matheson Tri-Gas Inc.（米国）、CalOx（米国）、Steelman Gases Pvt. Ltd.（インド）、Earlbeck Gases & Technology（米国）、Chengdu Taiyu Industrial Gases Co., Ltd.（中国）、Messer SE & CO. KGAA（ドイツ）、SOL SpA（イタリア）、Ellenbarrie Industrial Gases（インド）、Norco Inc.（米国）、Gulf Cryo（アラブ首長国連邦）など ...」をグローバル医療用亜酸化窒素市場の主要企業として認識しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。

★調査レポート[医療用亜酸化窒素のグローバル市場予測（～2029）：気体、液体] (コード：MD8935-24)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療用亜酸化窒素のグローバル市場予測（～2029）：気体、液体]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆